Author: Antonio Juberías Sánchez
Publisher: Editorial Reus
ISBN: 8429017550
Category : Law
Languages : es
Pages : 481
Book Description
Los altos costes asociados a la investigación y comercialización de nuevas moléculas son el origen de los elevados precios de los medicamentos, que encarecen el gasto farmacéutico soportado por la sociedad. La presencia de genéricos supone la disponibilidad de medicamentos con inferior costo que los innovadores, pero cuya similitud esencial les proporciona eficacia equivalente en el ámbito terapéutico, convirtiéndoles en una eficaz herramienta de control del gasto farmacéutico. La comercialización de estos medicamentos aprovecha parte del esfuerzo y la tecnología utilizados por la industria innovadora, lo que se traduce en un inferior precio, y da lugar a ciertas implicaciones sobre instituciones propias del derecho privado como la propiedad, el derecho de autor, derecho de patente, el diseño, la marca o la responsabilidad derivada de los daños provocados por defectos en el medicamento. A lo largo de esta obra se lleva a cabo un estudio pormenorizado de estas implicaciones, y se ponen de relieve determinados aspectos que pueden influir en la introducción y disponibilidad de genéricos en el mercado farmacéutico, así como la necesidad de conjugar su existencia con la del medicamento innovador. Esta obra está dirigida tanto a juristas como a profesionales del medicamento, en las vertientes de fabricación y dispensación, que deseen conocer las relaciones establecidas entre los medicamentos genéricos y determinadas instituciones de derecho privado que influirán en su comercialización.
Los medicamentos genéricos, entre la propiedad privada y la salud pública
Author: Antonio Juberías Sánchez
Publisher: Editorial Reus
ISBN: 8429017550
Category : Law
Languages : es
Pages : 481
Book Description
Los altos costes asociados a la investigación y comercialización de nuevas moléculas son el origen de los elevados precios de los medicamentos, que encarecen el gasto farmacéutico soportado por la sociedad. La presencia de genéricos supone la disponibilidad de medicamentos con inferior costo que los innovadores, pero cuya similitud esencial les proporciona eficacia equivalente en el ámbito terapéutico, convirtiéndoles en una eficaz herramienta de control del gasto farmacéutico. La comercialización de estos medicamentos aprovecha parte del esfuerzo y la tecnología utilizados por la industria innovadora, lo que se traduce en un inferior precio, y da lugar a ciertas implicaciones sobre instituciones propias del derecho privado como la propiedad, el derecho de autor, derecho de patente, el diseño, la marca o la responsabilidad derivada de los daños provocados por defectos en el medicamento. A lo largo de esta obra se lleva a cabo un estudio pormenorizado de estas implicaciones, y se ponen de relieve determinados aspectos que pueden influir en la introducción y disponibilidad de genéricos en el mercado farmacéutico, así como la necesidad de conjugar su existencia con la del medicamento innovador. Esta obra está dirigida tanto a juristas como a profesionales del medicamento, en las vertientes de fabricación y dispensación, que deseen conocer las relaciones establecidas entre los medicamentos genéricos y determinadas instituciones de derecho privado que influirán en su comercialización.
Publisher: Editorial Reus
ISBN: 8429017550
Category : Law
Languages : es
Pages : 481
Book Description
Los altos costes asociados a la investigación y comercialización de nuevas moléculas son el origen de los elevados precios de los medicamentos, que encarecen el gasto farmacéutico soportado por la sociedad. La presencia de genéricos supone la disponibilidad de medicamentos con inferior costo que los innovadores, pero cuya similitud esencial les proporciona eficacia equivalente en el ámbito terapéutico, convirtiéndoles en una eficaz herramienta de control del gasto farmacéutico. La comercialización de estos medicamentos aprovecha parte del esfuerzo y la tecnología utilizados por la industria innovadora, lo que se traduce en un inferior precio, y da lugar a ciertas implicaciones sobre instituciones propias del derecho privado como la propiedad, el derecho de autor, derecho de patente, el diseño, la marca o la responsabilidad derivada de los daños provocados por defectos en el medicamento. A lo largo de esta obra se lleva a cabo un estudio pormenorizado de estas implicaciones, y se ponen de relieve determinados aspectos que pueden influir en la introducción y disponibilidad de genéricos en el mercado farmacéutico, así como la necesidad de conjugar su existencia con la del medicamento innovador. Esta obra está dirigida tanto a juristas como a profesionales del medicamento, en las vertientes de fabricación y dispensación, que deseen conocer las relaciones establecidas entre los medicamentos genéricos y determinadas instituciones de derecho privado que influirán en su comercialización.
Los medicamentos genéricos, entre la propiedad y la salud pública
Author: Antonio Juberías Sánchez
Publisher:
ISBN:
Category : Drugs
Languages : es
Pages : 477
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : es
Pages : 477
Book Description
Cloud Computing, Big Data & Emerging Topics
Author: Marcelo Naiouf
Publisher: Springer
ISBN: 9783030848248
Category : Computers
Languages : en
Pages : 203
Book Description
This book constitutes the revised selected papers of the 9th International Conference on Cloud Computing, Big Data & Emerging Topics, JCC-BD&ET 2021, held in La Plata, Argentina*, in June 2021. The 12 full papers and 2 short papers presented were carefully reviewed and selected from a total of 37 submissions. The papers are organized in topical sections on parallel and distributed computing; machine and deep learning; big data; web and mobile computing; visualization.. *The conference was held virtually due to the COVID-19 pandemic.
Publisher: Springer
ISBN: 9783030848248
Category : Computers
Languages : en
Pages : 203
Book Description
This book constitutes the revised selected papers of the 9th International Conference on Cloud Computing, Big Data & Emerging Topics, JCC-BD&ET 2021, held in La Plata, Argentina*, in June 2021. The 12 full papers and 2 short papers presented were carefully reviewed and selected from a total of 37 submissions. The papers are organized in topical sections on parallel and distributed computing; machine and deep learning; big data; web and mobile computing; visualization.. *The conference was held virtually due to the COVID-19 pandemic.
Child Friendly Schools Manual
Author:
Publisher: UNICEF
ISBN: 9280643762
Category : Business & Economics
Languages : en
Pages : 244
Book Description
This Child-Friendly Schools (CFS) Manual was developed during three-and-a-half years of continuous work, involving the United Nations Children's Fund education staff and specialists from partner agencies working on quality education. It benefits from fieldwork in 155 countries and territories, evaluations carried out by the Regional Offices and desk reviews conducted by headquarters in New York. The manual is a part of a total resource package that includes an e-learning package for capacity-building in the use of CFS models and a collection of field case studies to illustrate the state of the art in child-friendly schools in a variety of settings.
Publisher: UNICEF
ISBN: 9280643762
Category : Business & Economics
Languages : en
Pages : 244
Book Description
This Child-Friendly Schools (CFS) Manual was developed during three-and-a-half years of continuous work, involving the United Nations Children's Fund education staff and specialists from partner agencies working on quality education. It benefits from fieldwork in 155 countries and territories, evaluations carried out by the Regional Offices and desk reviews conducted by headquarters in New York. The manual is a part of a total resource package that includes an e-learning package for capacity-building in the use of CFS models and a collection of field case studies to illustrate the state of the art in child-friendly schools in a variety of settings.
Pharmaceutical Innovation and Access to Medicines
Author: OECD
Publisher: Org. for Economic Cooperation & Development
ISBN: 9789264307384
Category : Drug accessibility
Languages : en
Pages : 0
Book Description
This report reviews the important role of medicines in health sytems, describes recent trends in pharmaceutical expenditure and financing, and summarises the approaches used by OECD countries to determine coverage and pricing.
Publisher: Org. for Economic Cooperation & Development
ISBN: 9789264307384
Category : Drug accessibility
Languages : en
Pages : 0
Book Description
This report reviews the important role of medicines in health sytems, describes recent trends in pharmaceutical expenditure and financing, and summarises the approaches used by OECD countries to determine coverage and pricing.
The Routledge Spanish Bilingual Dictionary of Psychology and Psychiatry
Author: Steven M. Kaplan
Publisher: Taylor & Francis US
ISBN: 9780415587747
Category : English language
Languages : en
Pages : 0
Book Description
The Routledge Spanish Bilingual Dictionary of Psychology and Psychiatry contains over 100,000 entries making this the most comprehensive and up-to-date dictionary of its kind. The Dictionary provides concise, comprehensive and current coverage of every word or phrase used in the study and practice of psychiatry and psychology. This valuable reference tool covers all disciplines and sub-disciplines, both research-based and clinical. This is a vital resource to those in the healthcare professions, to academicians and to those who work in translation and/or interpretation, healthcare and the law who are in contact with the English and Spanish speaking communities.
Publisher: Taylor & Francis US
ISBN: 9780415587747
Category : English language
Languages : en
Pages : 0
Book Description
The Routledge Spanish Bilingual Dictionary of Psychology and Psychiatry contains over 100,000 entries making this the most comprehensive and up-to-date dictionary of its kind. The Dictionary provides concise, comprehensive and current coverage of every word or phrase used in the study and practice of psychiatry and psychology. This valuable reference tool covers all disciplines and sub-disciplines, both research-based and clinical. This is a vital resource to those in the healthcare professions, to academicians and to those who work in translation and/or interpretation, healthcare and the law who are in contact with the English and Spanish speaking communities.
Health Care Cost, Quality, and Outcomes
Author: Marc L. Berger
Publisher: International Society for Pharmacoeconomics and Ou
ISBN: 9780974328904
Category : Medical care
Languages : en
Pages : 264
Book Description
"It includes over 100 entries covering more than 400 terms related to health care and the clinical, economic and patient-reported outcomes of that care as well as to the overall management and regulation of health care."--P. xiii.
Publisher: International Society for Pharmacoeconomics and Ou
ISBN: 9780974328904
Category : Medical care
Languages : en
Pages : 264
Book Description
"It includes over 100 entries covering more than 400 terms related to health care and the clinical, economic and patient-reported outcomes of that care as well as to the overall management and regulation of health care."--P. xiii.
The Sustainable Development Goals Report 2017
Author: United Nations Publications
Publisher:
ISBN: 9789211013689
Category : Business & Economics
Languages : en
Pages : 60
Book Description
The aim of this report is to present an overview of the 17 Goals using data currently available to highlight the most significant gaps and challenges.
Publisher:
ISBN: 9789211013689
Category : Business & Economics
Languages : en
Pages : 60
Book Description
The aim of this report is to present an overview of the 17 Goals using data currently available to highlight the most significant gaps and challenges.
Making Medicines Affordable
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Cities of Tomorrow
Author: Peter Hall
Publisher: Wiley-Blackwell
ISBN: 9780631199434
Category : Social Science
Languages : en
Pages : 502
Book Description
Cities of Tomorrow is a critical history of planning in theory and practice in the twentieth century, as well as of the social and economic problems and opportunities that gave rise to it. Trenchant, perceptive, global in coverage, this book is an unrivalled account of its crucial subject. The third edition of Cities of Tomorrow is comprehensively revised to take account of abundant new literature published since its original appearance, and to view the 1990s in historical perspective. This is the definitive edition, reviewing the development of the modern planning movement over the entire span of the twentieth century.
Publisher: Wiley-Blackwell
ISBN: 9780631199434
Category : Social Science
Languages : en
Pages : 502
Book Description
Cities of Tomorrow is a critical history of planning in theory and practice in the twentieth century, as well as of the social and economic problems and opportunities that gave rise to it. Trenchant, perceptive, global in coverage, this book is an unrivalled account of its crucial subject. The third edition of Cities of Tomorrow is comprehensively revised to take account of abundant new literature published since its original appearance, and to view the 1990s in historical perspective. This is the definitive edition, reviewing the development of the modern planning movement over the entire span of the twentieth century.